October 1, 2022

Photo Credits: Reuters

Every one person in four across the world will not receive Covid-19 vaccine by 2022

Spread the love

Around one individual in every set of four people across the world may not receive the Covid-19 vaccine by 2022 as rich and advanced countries comprising of as less as 15 percent of the global population have accounted for reservation of 51 per cent of the doses of the most promising vaccines, as per the report of researchers revealed on Tuesday.

The economically poor and middle-class countries, which account to over 85 per cent of the global population, would have to share the remaining hold of the vaccines, according to the researchers representing the Johns Hopkins Bloomberg School of Public Health, United States.

The researchers have iterated on the adequate response which is expected from the high-income countries “to share in an equitable distribution of Covid-19 vaccines across the world”.

The researchers further added, “The uncertainty over global access to Covid-19 vaccines traces not only to ongoing clinical testing, but also from the failure of governments and vaccine manufacturers to be more transparent and accountable over these arrangements.”

Considering the records till December 15, the advanced countries have pre-ordered around 7.5 billion doses from 13 manufacturing companies. Japan, Australia and Canada have reserved for over one billion doses but estimate only per cent of the total Coronavirus cases.

As per the paper, despite the manufacturing and developing companies reached their maximum production capacity, as many as one-fourth of the world’s population will still not receive the vaccine for another year or more than that.

Earlier, last week, the People’s Vaccine Alliance coalition stated that pharmaceutical companies are urged to share their technology along with the intellectual property via the World Health Organization (WHO) for manufacturing of more doses of the vaccine.

According to the researchers of the John Hopkins, the COVAX facility of WHO will play a pivotal role in further increasing the access to the approved Covid-19 vaccine candidates, however, only 500 million doses have been reserved by it so far, which is nearly one-fourth of its target of at least attaining 2 billion doses till the end of 2021.

Inaugurated in April, the pact was introduced with the objective of garnering funds from the rich countries and pace up the manufacture, development and distribution of Covid-19 vaccines throughout the world.

error: Content is protected !!